[Cytostatic therapy of chronic myelosis and polycythemia vera with myelobromol (dibrommannitol)].
D000469:Alkaline Phosphatase / Q000097:blood; D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001792:Blood Platelets; D002066:Busulfan / Q000627:therapeutic use; D006400:Hematocrit; D006452:Hemoglobinometry; D006801:Humans; D007408:Intestinal Absorption; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D007958:Leukocyte Count; D007962:Leukocytes / Q000201:enzymology; D008353:Mannitol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011087:Polycythemia Vera / Q000188:drug therapy*; D012156:Reticulocytes
D000477:Alkylating Agents; D008353:Mannitol; D000469:Alkaline Phosphatase; D002066:Busulfan
Zytostatische Therapie der chronischen Myelose und Polycythaemia vera mit Myelobromol (Dibrommannitol)